52648

🔬 CPT 52648 — Laser Vaporization of Prostate

Quick Reference

wRVU: 15.45 | Global Period: 090 (90 days) | Assistant Payable: ❌ No | Bilateral Indicator: 0

---

📋 Clinical Description

CPT 52648 describes transurethral laser vaporization of the prostate, in which the surgeon advances a resectoscope or endoscope through the urethra to visualize the prostate, then uses a side-firing or end-firing laser to vaporize excess prostatic adenoma tissue, creating an immediate wide cavity in the urethral channel. This is the laser equivalent of TURP (52601) in tissue effect — both produce a resection cavity — but 1 achieves this through instantaneous vaporization of tissue rather than electrosurgical resection. The critical distinction within the laser family is technique: 52648 captures vaporization and ablation (no tissue retrieval), whereas 52649 captures enucleation with morcellation (whole-lobe removal followed by fragmentation and irrigation). Note: CPT 52647 (laser coagulation) was deleted effective January 1, 2026 and is no longer a valid code.¹

Benign prostatic hyperplasia (BPH) is the non-malignant overgrowth of prostatic stromal and glandular cells that compresses the urethra, causing lower urinary tract symptoms including obstructive voiding, nocturia, urgency, and incomplete bladder emptying; untreated, it may progress to acute urinary retention, recurrent UTI, bladder trabeculation, or renal insufficiency. When documented with LUTS, code N40.1 is the most appropriate primary diagnosis; N40.0 applies when BPH is documented without LUTS.

This procedure may be performed in the following clinical contexts:

• BPH with moderate-to-severe LUTS refractory to medical management — Laser vaporization is selected when alpha-blockers and 5-alpha reductase inhibitors have failed to provide adequate relief and the patient’s prostate volume is suitable for the vaporization approach.
• BPH with acute or chronic urinary retention — Patients presenting with inability to void spontaneously and catheter dependence; vaporization relieves the mechanical obstruction and facilitates catheter-free voiding.
• BPH in anticoagulated or high-bleeding-risk patients — The hemostatic properties of most vaporization lasers (especially GreenLight/KTP) make 52648 preferable over electrosurgical TURP in patients on warfarin, DOACs, or with coagulopathy, because vaporization coagulates vessels simultaneously.
• Prostate volume suitable for vaporization (typically <80-120 cc) — Very large glands (>150 cc) may be better served by enucleation (52649) or open simple prostatectomy; documentation of prostate volume by TRUS or MRI supports the clinical decision and the code selection.
• Recurrent BPH/residual adenoma following prior prostatectomy — 52648 is appropriate whether this is the patient’s first or a repeat laser procedure; unlike TURP (52601 first, 52630 repeat), there is no first/repeat distinction for laser codes.

---

🔬 Anatomical & Procedural Considerations

Laser Modality	Mechanism	Key Coding & Clinical Notes
GreenLight / KTP / XPS (532 nm)	Photoselective vaporization (PVP): laser energy absorbed by hemoglobin in prostatic tissue causes immediate vaporization; creates cavity with hemostasis built in	Most common modality for 52648; documentation should state “vaporization” or “PVP”; results are virtually immediate with minimal bleeding
Holmium:YAG Laser (Ho:YAG) — ablative use	Contact fiber ablates/vaporizes prostate tissue; used in HoLAP (Holmium laser ablation) technique	Code is 52648 regardless of whether Ho:YAG or KTP is used — code choice is based on technique effect, not laser brand or wavelength
Thulium Laser (ThuVAP)	High-powered continuous-wave laser that vaporizes adenoma; newer modality with outcomes comparable to GreenLight	Still codes to 52648 if vaporization is the technique; documentation must clearly state the tissue effect

Clinical Pearl

The type of laser used does NOT determine the CPT code. Code selection is driven entirely by the tissue effect on the adenoma: vaporization → 52648; enucleation with morcellation → 52649. A coder who sees “Holmium laser” in the operative note and automatically assigns 52649 is making the most common error in this family. Read the technique description: if no morcellator was used and the tissue was immediately vaporized without removal, the correct code is 52648.

---

✅ Procedure Includes

• Preoperative endoscopic assessment of the urethra and bladder
• Cystourethroscopy, urethral calibration, dilation, meatotomy — all bundled
• Internal urethrotomy if performed at the same session — bundled
• Transurethral resection of prostate if performed during the same session — bundled
• Intraoperative laser vaporization of the prostatic adenoma with hemostasis
• Control of postoperative bleeding
• Any vasectomy performed concurrently — bundled
• Catheter placement at end of procedure

---

---

❌ Excludes / Do Not Report Together

Code	Description	Relationship to 52648
52601	Transurethral electrosurgical resection of prostate — first procedure	Mutually exclusive: 52601 is electrosurgical TURP; 52648 is laser vaporization; both describe complete prostate procedures — report only one per session
52630	Transurethral electrosurgical resection of prostate — repeat procedure	Same mutual exclusivity as 52601; repeat laser procedures still use 52648, not 52630
52649	Laser enucleation of prostate with morcellation	Mutually exclusive: enucleation is a distinct technique — use 52649 only when the adenoma lobe is enucleated intact and then morcellated; do not report both 52648 and 52649 for the same session
52450	Transurethral incision of prostate (TUIP)	Not separately reportable; TUIP performed at the same session using a laser is still 52450, not 52648 — laser modality does not change the root operation
E/M codes (992xx)	Office visit, any level	Separately reportable only when modifier -25 is appended to the E/M code, documenting a significant, separately identifiable E/M service beyond the routine pre-procedure assessment

Bundling Alert — Global Period is 090, Not 000 or 010

All routine pre-op (day before surgery), intraoperative, and 90-day post-op care is bundled into the 52648 payment. Billing a related post-op E/M within the 90-day window without the appropriate modifier will trigger recoupment. For unrelated E/M visits within the global period, append modifier -24 to the E/M and document the unrelated nature explicitly. The most common audit finding is post-op bladder irrigation or catheter change visits billed without a modifier — these are bundled if related to the prostatectomy.

---

🌳 Code Tree — Surgery: Vesical Neck and Prostate

CPT 52400-52700  Surgery: Vesical Neck and Prostate
│
├── 52400-52520  Cystourethroscopy and related endoscopic procedures
│
├── 52600-52649  Prostatectomy / Transurethral Surgical Procedures
│   ├── 52601  TURP, electrosurgical, first procedure  (Global: 090)
│   ├── 52630  TURP, electrosurgical, repeat procedure  (Global: 090)
│   ├── 52647  Laser coagulation of prostate  ← DELETED 2026
│   ├── ▶▶ 52648 ◀◀  Laser vaporization of prostate, complete  ← YOU ARE HERE  (Global: 090)
│   └── 52649  Laser enucleation of prostate with morcellation  (Global: 090)
│
└── 52700  Transurethral drainage of prostatic abscess  (Global: 090)

---

💰 RVU & Reimbursement Profile

Component	Value
Work RVU (wRVU)	15.45 (2026 CMS MPFS; reflects 2.5% efficiency adjustment; verify CMS-1832-F for final values)
Global Period	090 (90 days)
Bilateral Indicator	0 — Not a bilateral procedure; bilateral reduction rules do not apply
Assistant Surgeon	❌ Not payable
Co-Surgeon	❌ Not applicable
Team Surgery	❌ Not applicable
PC/TC Split	❌ No — procedure code only (Indicator 0)
Modifier -51 Exempt	No
Anesthesia	General or spinal/regional anesthesia standard; no separate anesthesia component included in CPT payment — separately billed under anesthesia codes

2026 Reimbursement Note

CMS finalized a −2.5% efficiency adjustment to wRVUs for nearly all non-time-based procedural codes effective January 1, 2026. 52648 was also impacted by PE input revisions (removal of 6 minutes clinical labor and equipment time). Total Medicare physician payment for 52648 in 2026 is approximately $528\ast \ast atthenationalaverage.OPPS/ASCfacilitypaymentisapproximately\ast \ast$5,478 / $2,730 respectively per CMS-1832-F. Always verify against your MAC’s locality-adjusted fee schedule.

---

🏷️ Modifier Reference

Modifier	Name	When to Apply
-52	Reduced Services	Procedure partially completed — document reason clearly; use when vaporization was started but not fully completed due to patient or equipment factors
-53	Discontinued Procedure	Procedure stopped due to patient safety concern before reaching the prostate; document reason thoroughly
-58	Staged or Related Procedure	Planned staged repeat vaporization within the 90-day global period; document as planned/staged in original operative note
-78	Unplanned Return to OR	Unplanned return for complication (bleeding, clot retention) during global period
-79	Unrelated Procedure During Postoperative Period	Unrelated surgical procedure performed within the 90-day global window; document unrelated nature
-24	Unrelated E/M During Postoperative Period	Applied to the E/M code when the patient is seen within the 90-day global window for a condition unrelated to the prostatectomy; document the unrelated condition
-25	Significant, Separately Identifiable E/M	Applied to the E/M code — not 52648 — when a new problem or separately documented decision for treatment occurs on the day of the procedure
-51	Multiple Procedures	When 52648 is performed alongside other separately reportable surgical procedures at the same session
-59	Distinct Procedural Service	When payers inappropriately bundle 52648 with another distinct service at the same session; documents separate service

---

🩺 Common ICD-10-CM Pairings

Benign Prostatic Hyperplasia — Primary Grouping

ICD-10 Code	Description	HCC?	Clinical Notes
N40.1	Benign prostatic hyperplasia with lower urinary tract symptoms	❌ No	Most common pairing — use when LUTS (obstructive/irritative) are explicitly documented by the provider; do not assume LUTS — query if not stated
N40.0	Benign prostatic hyperplasia without lower urinary tract symptoms	❌ No	Use only when BPH is documented without any LUTS; patient may present for elective procedure or with retention coded separately
R33.8	Other retention of urine	❌ No	When acute or chronic urinary retention is the presenting problem driving the procedure; may be added to N40.1
R33.9	Retention of urine, unspecified	❌ No	Use only when retention is documented but specificity is absent and provider cannot be queried

Associated / Complicating Conditions

ICD-10 Code	Description	HCC?	Clinical Notes
N41.0	Acute prostatitis	❌ No	When concurrent prostatitis is documented; consider query if clinical picture suggests infection
N32.0	Bladder neck obstruction	❌ No	When bladder neck obstruction is explicitly documented as a contributing or primary diagnosis
N39.0	Urinary tract infection, site not specified	❌ No	When pre-op or concurrent UTI is documented and treated

Underlying Etiology / Complication Codes

ICD-10 Code	Description	HCC?	Clinical Notes
N99.89	Other postprocedural complications and disorders of genitourinary system	❌ No	When patient returns within the global period for a documented complication of the laser vaporization
T83.518A	Infection and inflammatory reaction due to indwelling urethral catheter, initial encounter	❌ No	When catheter-associated UTI is a documented complication following the procedure

Coding Specificity Reminder

The most common specificity gap for 52648 pairings is failing to distinguish N40.1 (with LUTS) from N40.0 (without LUTS). The presence of urinary frequency, urgency, weak stream, nocturia, or retention in the provider’s documentation is sufficient to code N40.1 — do not code N40.0 when any LUTS is documented. Query the provider whenever the BPH note is silent on symptom status. ICD-10-CM specificity requirements are not optional.

---

🏥 MS-DRG Considerations (Inpatient)

Inpatient Coding Reminder

CPT 52648 is performed primarily in the outpatient hospital (HOPD) or ASC setting. Inpatient admission for laser vaporization of the prostate is uncommon but may occur for large-gland BPH, patients on anticoagulation, or those with significant comorbidities. When an ICD-10-PCS Destruction code is the procedure on an inpatient claim, the principal diagnosis of N40.1 or N40.0 maps to MDC 11 — Diseases and Disorders of the Kidney and Urinary Tract, and groups to the DRG 665 / 666 / 667 Prostatectomy triplet based on CC/MCC tier. Confirm grouping with your facility’s FY2026 DRG grouper.

---

🔧 ICD-10-PCS Equivalents (Inpatient Facility Coding)

Note

For inpatient claims, the PCS root operation for laser vaporization is Destruction (character 5) — the body part is physically eradicated by energy without physical removal of tissue. This distinguishes laser vaporization (52648 → Destruction) from laser enucleation with morcellation (52649 → Resection or Excision depending on technique). The approach is Via Natural or Artificial Opening (7) for standard transurethral access, or Via Natural or Artificial Opening Endoscopic (8) when the endoscope is used.

PCS Code	Full Description	Applicable Modality
0V507ZZ	Destruction of Prostate, Via Natural or Artificial Opening	Laser vaporization via resectoscope without separate endoscopic visualization
0V508ZZ	Destruction of Prostate, Via Natural or Artificial Opening Endoscopic	Laser vaporization with direct endoscopic visualization

PCS Character Analysis — 0V507ZZ

Position	Character	Value	Definition
1	Section	0	Medical and Surgical
2	Body System	V	Male Reproductive System
3	Root Operation	5	Destruction (physical eradication of all or part of a body part by the direct use of energy, force, or destructive agent)
4	Body Part	0	Prostate
5	Approach	7	Via Natural or Artificial Opening
6	Device	Z	No Device
7	Qualifier	Z	No Qualifier

PCS Root Operation: Destruction (5) vs. Resection (T)

• Use Destruction (5) when the laser vaporizes/ablates the prostatic adenoma in situ — no tissue is removed from the body; this maps to 52648
• Use Resection (T) when the entire prostate is removed (radical prostatectomy) — a different root operation and code family entirely
• For enucleation with morcellation (52649), the root operation is Excision (B) or Resection (T) depending on whether a portion or the entirety is removed — see the 52649 note for the character analysis

---

📝 Coding Examples

---

Example 1 — ASC: BPH with Urinary Retention, GreenLight PVP

Clinical Scenario: A 71-year-old male with a 3-year history of BPH and progressive LUTS presents with acute urinary retention requiring Foley catheter placement. TRUS estimated prostate volume at 75 cc. Urologist performs GreenLight photoselective vaporization of the prostate (PVP) under spinal anesthesia in the ASC. Operative note documents: “Using the GreenLight XPS 180W laser with side-firing fiber, systematic laser vaporization of the prostatic adenoma was completed, creating a wide channel from bladder neck to apex. Excellent hemostasis achieved. No separate TURP or meatotomy required.” Catheter removed on postoperative day 2; patient voided spontaneously.

Field	Code	Rationale
CPT	52648	Laser vaporization (PVP), complete; technique and modality confirmed in operative note; no morcellation → not 52649
PDx	N40.1	BPH with documented LUTS (urinary retention is an obstructive symptom of BPH)
SDx	R33.8	Acute urinary retention documented as the presenting complication driving the surgical decision

Note

Retention of urine (R33.8) is appropriately coded as an additional diagnosis when separately documented; it supports medical necessity and increases the clinical picture. If the urologist documents only “BPH” without explicit LUTS language, query before applying N40.1 over N40.0.

---

Example 2 — Outpatient Hospital: BPH on Anticoagulation, Same-Day Decision for Surgery

Clinical Scenario: A 68-year-old male on rivaroxaban for atrial fibrillation presents for an office urology consultation for BPH-related LUTS that have been refractory to tamsulosin for 18 months. At the appointment, the urologist reviews the cystoscopy findings and makes the decision to proceed with same-day laser vaporization under a bridging protocol in the hospital outpatient department. A separate, documented E/M note addresses the decision-making, anticoagulation risk, and informed consent beyond the routine pre-procedure assessment. Laser vaporization is completed without incident.

Field	Code	Rationale
CPT 1	99213-25	Significant, separately identifiable E/M for BPH decision-making and anticoagulation risk counseling; -25 on the E/M, not on 52648
CPT 2	52648	Laser vaporization, complete
PDx	N40.1	BPH with LUTS — primary reason for procedure
SDx	I48.91	Long-standing persistent atrial fibrillation — comorbidity affecting surgical approach and anticoagulation management

Warning

Modifier -25 belongs on the E/M code, not on 52648. The most common audit finding is the reverse. The E/M documentation must clearly address a problem or decision separate from the pre-procedure evaluation — the anticoagulation management discussion and risk-benefit counseling in this scenario satisfies that standard. A note that consists solely of “patient to undergo laser vaporization today; consented” will not support a separately billed E/M.

---

Example 3 — Inpatient: Large-Gland BPH with CKD, Postoperative Hematuria Return

Clinical Scenario: A 75-year-old male with BPH (prostate volume 110 cc by TRUS), CKD stage 3b, and a prior history of pelvic radiation is admitted to the inpatient unit for laser vaporization of the prostate given comorbidity risk. Laser vaporization is completed on day 1. On postoperative day 4, patient is still inpatient when significant clot retention occurs, requiring a return to OR for clot evacuation and hemostasis under 52648’s 90-day global period.

Field	Code	Rationale
CPT 1	52648-78	Return to OR for complication (clot retention/hematuria) within the 90-day global window; modifier -78 = unplanned return to OR during postoperative period
CPT 2	52648	Original procedure — initial laser vaporization
PDx	N40.1	BPH with LUTS — principal diagnosis for admission
SDx	N18.32	CKD stage 3b — comorbidity impacting care and risk; CC/MCC impact on DRG grouping
SDx	N99.89	Postprocedural complication of genitourinary system — clot retention following laser vaporization

Note

Global period reminder: Modifier -78 is the correct modifier for an unplanned return to the OR during the 90-day global period for a complication of the original surgery. This modifier reduces reimbursement to the intraoperative component only (no pre-op or post-op value). If the return OR visit is for a completely unrelated problem, modifier -79 is appropriate instead. Document the relationship (or lack thereof) to the original procedure explicitly in the operative note.

---

⚠️ Common Coding Pitfalls

• Coding based on laser type rather than technique: The most prevalent error in this code family is assigning 52648 or 52649 based on seeing “Holmium laser” or “GreenLight laser” in the documentation rather than identifying what the laser actually did to the tissue. Any laser can be used to vaporize or enucleate; always read past the equipment description to find the technique. If the operative note is ambiguous, query the operating urologist before assigning a code.

• Using 52647 in 2026: CPT 52647 (laser coagulation of prostate) was deleted effective January 1, 2026, and is no longer a valid code. Claims submitted with 52647 for dates of service on or after 1/1/2026 will be rejected. If the documentation describes laser coagulation of the prostate, contact the surgeon to clarify technique — in current practice, vaporization (52648) is nearly always the correct code; true laser coagulation is rarely performed today.

• Failing to apply the 90-day global period to post-op visits: The 90-day global package for 52648 includes all routine post-op visits related to the procedure. The single most common recoupment finding is billing a related cystoscopy or catheter management visit during the 90-day window without a modifier. Any billable service within the global period that is related to the prostatectomy must include the appropriate modifier (-24 for unrelated E/M, -78 for unplanned OR return, -79 for unrelated procedure).

• Coding TURP in addition to 52648: The descriptor for 52648 explicitly states that transurethral resection of the prostate is included if performed. Separately reporting 52601 or 52630 alongside 52648 for the same session is an NCCI bundling violation and will result in recoupment of the lesser-valued code.

• N40.0 when LUTS is present: Defaulting to N40.0 (BPH without LUTS) when the documentation mentions any urinary symptom — urgency, frequency, nocturia, incomplete emptying, weak stream, hesitancy, or retention — is a specificity error.N40.1 is the correct code whenever LUTS is documented or clearly implied. If the record is ambiguous, this is a query trigger.

• Assigning 52648 for a partial or incomplete vaporization without documentation: If the procedure was started but not completed, the claim must reflect the work actually performed. Modifier -52 (reduced services) should be appended and the reason for incomplete treatment documented. Billing 52648 for a procedure that did not reach the level of a “complete” vaporization without a modifier exposes the claim to audit and allegation of upcoding.

---

📎 Sources

¹ AMA CPT 2026 Professional Edition · ² CMS 2026 Medicare Physician Fee Schedule Final Rule (CMS-1832-F) · ³ CMS RVU26A Relative Value Files (October 2025 release) · ⁴ NCCI Policy Manual Chapter 5, CMS 2026 · ⁵ ICD-10-CM Official Guidelines for Coding and Reporting FY2026 · ⁶ ICD-10-PCS Official Guidelines for Coding and Reporting FY2026 · ⁷ American Urological Association — 2026 MPFS Proposed and Final Rule Deep-Dive Summary · ⁸ Boston Scientific — 2026 Coding & Payment Quick Reference: Prostate Health (sourced from CMS-1832-F Addendum B) · ⁹ AAPC Urology Coding Alert — “Pinpoint Spot-On Coding for Laser Prostate Procedures” (August 2017) · ¹⁰ AAPC Urology Coding Alert — “Make Coding, Anatomical Distinctions Between Prostatic Laser Procedures” (February 2021)